Tags: Drug.
Lucinactant (trade name Surfaxin) is a liquid medication used to treat Infant Respiratory Distress Syndrome in infants. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on March 6 2012.
Loading...
This page contains content from the copyrighted Wikipedia article "Lucinactant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.